Table 3.

Univariate analyses of the expression of miR-302b, EphA2 with the clinicopathologic characteristics in the training and validation cohorts.

Variable	n	Training set			n	Validation set
		Median OS (months)	P			Median OS (months)	P
Age (years)
<60	42	11.4	0.115		55	11.3	0.131
≥60	42	10.0			73	11.3
Gender
Male	42	10.4	0.721		63	10.9	0.296
Female	42	10.4			65	11.5
Lauren's
Diffuse	46	10.4	0.991		76	10.5	0.055
Intestinal	38	10.4			52	12.5
Peritoneal metastasis
Yes	29	9.5	0.001		27	9.0	0.017
No	55	11.4			101	11.4
Liver metastasis
Yes	23	10.2	0.887		23	8.9	0.029
No	61	10.5			105	11.4
EphA2
High	71	10.0	<0.001		100	10.4	0.009
Low	13	13.2			28	12.5
miR302b			0.002				0.003
High	23	9.5			78	12.1
Low	61	12.5			50	10.4